AAAAAA

   
Results: 1-4 |
Results: 4

Authors: Febbo, PG Kantoff, PW
Citation: Pg. Febbo et Pw. Kantoff, Androgen receptor polymorphisms and prostate cancer risk, CONT CANC R, 2001, pp. 95-109

Authors: Shepard, TF Platz, EA Kantoff, PW Nelson, WG Isaacs, WB Freije, D Febbo, PG Stampfer, MJ Giovannucci, E
Citation: Tf. Shepard et al., No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study, CANC EPID B, 9(11), 2000, pp. 1267-1268

Authors: Febbo, PG Kantoff, PW Platz, EA Casey, D Batter, S Giovannucci, E Hennekens, CH Stampfer, MJ
Citation: Pg. Febbo et al., The V89L polymorphism in the 5 alpha-reductase type 2 gene and risk of prostate cancer, CANCER RES, 59(23), 1999, pp. 5878-5881

Authors: Febbo, PG Kantoff, PW Giovannucci, E Brown, M Chang, G Hennekens, CH Stampfer, M
Citation: Pg. Febbo et al., Debrisoquine hydroxylase (CYP2D6) and prostate cancer, CANC EPID B, 7(12), 1998, pp. 1075-1078
Risultati: 1-4 |